论文部分内容阅读
目的:观察阿奇霉素治疗儿童呼吸道感染的治疗效果,探讨其疗效及安全性。方法:将2013-2014年我院所收治的150例呼吸道感染的患儿随机分成治疗组和对照组。治疗组:在常规治疗基础上,静滴阿奇霉素10mg/(kg·d),连用5d,根据病情需要,口服给药阿奇霉素。对照组:静滴红霉素15-30mg/(kg·d),连用5d,根据病情需要,口服给药。比较两组的恢复时间及痊愈率、有效率和不良反应发生率。结果:与对照组相比,治疗组的退热时间、止咳时间、罗音消失时间短(P<0.05),总有效率高(P<0.05),不良反应发生率(P<0.05)。结论:阿奇霉素静脉治疗小儿呼吸道感染疗效显著,不良反应较少,具有很好的临床应用价值。
Objective: To observe the therapeutic effect of azithromycin in children with respiratory tract infection and to explore its curative effect and safety. Methods: 150 cases of respiratory tract infection in our hospital from 2013 to 2014 were randomly divided into treatment group and control group. Treatment group: on the basis of routine treatment, intravenous azithromycin 10mg / (kg · d), once every 5d, according to the needs of the disease, oral administration of azithromycin. Control group: intravenous erythromycin 15-30mg / (kg · d), once every 5 days, according to the needs of the disease, oral administration. The recovery time, cure rate, effective rate and incidence of adverse reactions in both groups were compared. Results: Compared with the control group, the total effective rate (P <0.05) and adverse reaction rate (P <0.05) in the treatment group were shorter than those in the control group (P <0.05). Conclusion: Azithromycin intravenous treatment of children with respiratory tract infection has a significant effect, fewer adverse reactions, with good clinical value.